WELLINGTON MANAGEMENT GROUP LLP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$120,903,000
-12.8%
10,272,054
+1.1%
0.03%
-12.9%
Q1 2019$138,672,000
+183.9%
10,159,082
+113.2%
0.03%
+158.3%
Q4 2018$48,843,000
-29.1%
4,765,123
+15.1%
0.01%
-20.0%
Q3 2018$68,934,000
-11.0%
4,140,169
-15.5%
0.02%
-11.8%
Q2 2018$77,420,000
+22.2%
4,899,955
-1.8%
0.02%
+21.4%
Q1 2018$63,354,000
+22.5%
4,988,478
+10.5%
0.01%
+27.3%
Q4 2017$51,697,000
-14.1%
4,515,093
-8.1%
0.01%
-21.4%
Q3 2017$60,183,000
+46.1%
4,912,870
+36.6%
0.01%
+40.0%
Q2 2017$41,188,000
-45.6%
3,597,231
-1.2%
0.01%
-44.4%
Q1 2017$75,728,000
+0.7%
3,640,788
+0.7%
0.02%
-5.3%
Q4 2016$75,170,000
-40.2%
3,613,997
-5.8%
0.02%
-38.7%
Q3 2016$125,714,000
+14.9%
3,836,272
-12.4%
0.03%
+10.7%
Q2 2016$109,367,000
+41.5%
4,379,963
+38.7%
0.03%
+40.0%
Q1 2016$77,310,000
+72.9%
3,156,865
+133.2%
0.02%
+66.7%
Q4 2015$44,715,000
+3350.2%
1,353,755
+3323.0%
0.01%
Q3 2015$1,296,000
-45.8%
39,549
-12.4%
0.00%
-100.0%
Q2 2015$2,393,000
-63.7%
45,169
-80.2%
0.00%
-50.0%
Q1 2015$6,585,000
-26.5%
228,169
-26.0%
0.00%0.0%
Q4 2014$8,965,000
+191.6%
308,189
+27.1%
0.00%
+100.0%
Q3 2014$3,074,000
-1.1%
242,419
+56.5%
0.00%0.0%
Q2 2014$3,109,000154,9190.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders